ALEXANDER FELT: Open Payments
NPI 1548619190 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 25 payments from 17 companies in 2025. Trend: 2023 $650 · 2024 $910 · 2025 $885
Food & beverage: $686Education: $199
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $199 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $155 |
| Sumitomo Pharma America, Inc. | 5 | $111 |
| Medtronic, Inc. | 1 | $93 |
| Boston Scientific Corporation | 1 | $81 |
| PFIZER INC. | 2 | $38 |
| UROGEN PHARMA, INC. | 1 | $27 |
| Integra LifeSciences Corporation | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $19 |
Products named: Nubeqa, INTERSTIM, AMS 700, GEMTESA, ORGOVYX, XTANDI, JELMYTO, Integra.
Industry payments across IN — which companies pay providers there.
